The Combination of Insulin-Like Growth Factor Receptor 1 (IGF1R) Antibody Cixutumumab and Mitotane as a First-Line Therapy for Patients with Recurrent/Metastatic Adrenocortical Carcinoma: a Multi-institutional NCI-Sponsored Trial
Titel:
The Combination of Insulin-Like Growth Factor Receptor 1 (IGF1R) Antibody Cixutumumab and Mitotane as a First-Line Therapy for Patients with Recurrent/Metastatic Adrenocortical Carcinoma: a Multi-institutional NCI-Sponsored Trial
Auteur:
Lerario, Antonio M. Worden, Francis P. Ramm, Carole A. Hasseltine, Elizabeth A. Stadler, Walter M. Else, Tobias Shah, Manisha H. Agamah, Edem Rao, Krishna Hammer, Gary D.